Attached files
file | filename |
---|---|
EX-32.2 - IGAMBIT CERTIFICATION - Clinigence Holdings, Inc. | exhibit322.htm |
EX-31.2 - IGAMBIT CERTIFICATION - Clinigence Holdings, Inc. | exhibit312.htm |
XML - IDEA: XBRL DOCUMENT - Clinigence Holdings, Inc. | R9999.htm |
EX-32.1 - IGAMBIT CERTIFICATION - Clinigence Holdings, Inc. | exhibit321.htm |
10-K - IGAMBIT 10-K DEC 2015 - Clinigence Holdings, Inc. | f2015igambitform10kdraft4132.htm |
Exhibit 31.1
CHIEF EXECUTIVE OFFICER CERTIFICATION
PURSUANT TO SECTION 302
I, John Salerno, certify that:
1. I have reviewed this Annual Report on Form 10-K of iGambit Inc. (the
Registrant);
2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made,
in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report.
3. Based on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the Registrant as of, and for, the periods
presented in this report;
4. The Registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and
have:
a) designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the Registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;
b) designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
c) evaluated the effectiveness of the Registrants disclosure controls and
procedures presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period covered by
this report based on such evaluation; and
d) disclosed in this report any change in the Registrants internal control over
financial reporting that occurred during the Registrants most recent fiscal
quarter (the Registrants fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the
Registrants internal control over financial reporting; and
5. The Registrants other certifying officer and I have disclosed, based on our most
recent evaluation of internal control over financial reporting to the Registrants
auditors and the audit committee of Registrants board of directors (or persons
performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation
of internal control over financial reporting which are reasonably likely to
adversely affect the Registrants ability to record, process, summarize and
report financial information; and
b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the Registrants internal control over
financial reporting.
Date: April 14, 2016 /s/ John Salerno
John Salerno
Chief Executive Officer
(Principal Executive Officer)